查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1804290

美容醫療的全球市場:各手術類型，各功能，各手術類型，各地區:市場規模，產業趨勢，機會分析，預測(2025年～2033年)

Global Aesthetic Medicine Market: By Procedure Type (Invasive Procedures and Non-Invasive Procedures), Region- Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033
出版日期: | 出版商: Astute Analytica | 英文 160 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

受消費者偏好變化、技術進步以及非侵入性和微創性解決方案日益普及的推動，美容醫學市場正從小眾奢侈品市場轉型為主流自我照護市場。 2024 年，該市場規模為 831.2 億美元，預計到 2033 年將達到 2,336.7 億美元，預測期內複合年增長率高達 12.17%。肉毒桿菌注射、塑身和嫩膚等療法已成為數百萬人日常生活的一部分，如同口腔衛生一樣成為日常護理，並由醫療水療中心、皮膚科診所和以美容為中心的新型初級保健模式構成了生態系統。

國際美容整形外科學會 (ISS) 預測，2023 年全球美容整形手術數量將達到約 3,500 萬例，這反映出消費者對該領域的快速接受。同時，當年美容醫療器材公司的創投超過 29 億美元，凸顯了機構對市場長期成長軌跡的強勁信心。從護理師主導的注射服務到提供美容手術的牙科診所，美容醫療如今已被納入更廣泛的健康和保健框架。

值得關注的市場發展

關鍵發展涵蓋醫療保健提供者和醫療器材創新。千禧世代和 Z 世代消費者正在推動對神經調節劑、唇部增強和預防性抗衰老治療的需求。皮秒雷射和射頻微針等新技術正在引入多種益處，可在一次治療中實現收緊、重塑和矯正色素沉著。

同時，人工智慧驅動的3D影像解決方案正在透過精準預測治療結果和優化劑量來改變患者的診療方式。市場參與者艾爾建美學 (Allergan Aesthetics)、高德美 (Galderma)、Cynosure、科醫人 (Lumenis)、Therapie Clinic 和 SKINovative 正在透過建立垂直整合模式、收購小型公司以及提供包含按服務收費和收益分成選項的設備租賃套餐，促進大規模臨床應用。

核心推動因素

醫療美容市場的主要成長動力是對恢復期極短的非侵入性手術的巨大需求。到2024年，全球非侵入性治療的收入將達到785億美元。 HIFU、射頻系統（包括Thermage和Morpheus8）和雷射換膚等療法越來越多地提供與傳統手術技術相當的療效，且無需恢復期。臨床數據顯示，以超音波為基礎的設備可達到與臉部拉皮術相當的膠原蛋白收縮深度，促使各大城市診所的 "午餐時間" 治療預約量激增。

投資正湧向該領域，預計到2023年，將有18.9億美元的風險投資投入到非侵入式平台。診所報告稱，非侵入式產品的獲利指標非常出色。 SKINovative每平方英尺的平均收入達到12,500美元，遠高於外科手術設備的8,900美元。此外，設備製造商正以創紀錄的速度進行創新。 Cynosure的Elite iQ和類似的多波長平台減少了設備冗餘，與傳統系統相比，每日患者吞吐量提高了4.5倍以上。

新興科技趨勢

一個決定性趨勢是將美容服務融入非傳統環境，尤其是牙科診所和醫療水療中心。這一多元化細分市場每年貢獻超過234億美元。 Heartland Dental和Aspen Dental等牙科集團目前正利用其現有的臨床能力，在數百家診所提供注射和臉部美容治療。例如，Aspen Dental已投資6,700萬美元用於提升醫療服務提供者的技能，每年每個診所新增收入超過78萬美元。

醫療水療模式同樣充滿活力，北美擁有超過8,750家診所，總收入達156億美元。治療診所平均每個診所的年銷售額為320萬美元，涵蓋45種服務項目。 VillageMD已撥款1.25億美元，為680家診所增加美容醫療服務。像Lumenis這樣的設備製造商正在透過提供創新的融資方案來支持這一趨勢，這些方案可以減輕資本投資負擔並促進更快的採用。

優化障礙

美容醫療市場的一個關鍵障礙是在不斷擴張的大型網路中保持實踐的一致性。注射技術和治療應用的差異會促使患者不滿和責任風險，每年對該行業造成約 89 億美元的損失。一個大型歐洲醫療網絡因治療效果不一致而面臨 1200 萬美元的法律和解。

為了應對這些課題，領先的醫療服務提供者正在投資專有訓練系統和人工智慧輔助治療平台。 SKINovative 的臨床卓越平台獲得了 4700 萬美元的開發資金支持，利用電腦視覺和即時回饋來標準化針深和角度，將醫生的差異性降低到 2 毫米以內。然而，實施一套完整的系統仍然成本高昂，每個站點需要 78 萬美元的初始投資，每年需要 14.5 萬美元的維護費用。

全球標準化也面臨監管障礙。一個國家批准的方案可能與另一個國家不相容，從而促使合規風險和患者治療效果的差異。為此，艾爾建美容 (Allergan Aesthetics) 投資 1.67 億美元打造培訓學院，而高德美 (Galderma) 的 "同一標準" 計劃旨在到 2026 年在全球範圍內認證 45,000 名醫療保健提供者，彰顯行業對始終如一的品質和安全的承諾。

詳細的市場區隔

市場區隔

按治療類型劃分，非侵入性手術將佔最大佔有率，到 2024 年將超過全球美容醫療市場的 52%。此領域包括肉毒桿菌、真皮填充劑、化學換膚和雷射治療，這些療法效果顯著，療效立竿見影，不適感和恢復期極短。預計 12.39% 的複合年增長率將持續佔主導地位，因為老齡化社會（尤其是城市地區）越來越多地選擇非手術美容護理。

先進的配方和技術正在提高功效和安全性，促進更廣泛的應用。診所和醫療水療中心正在利用這些治療日益普及的優勢，提供符合消費者不斷變化的便利性和自主性偏好的門診治療選擇。

各市場區隔明細

各手術類型

  • 侵入性手術
  • 豐胸法
  • 抽脂
  • 鼻子的整形
  • 眼皮的手術
  • 腹部整形
  • 其他
  • 非侵入性次序
  • 肉毒桿菌注射
  • 軟組織填充物
  • 果酸換膚
  • 雷射脫毛
  • 微晶換膚術
  • 其他

區域洞察

區域細分分析

歐洲持續引領全球美容醫療市場，市佔率達27.7%，年銷售額達309.7億美元。德國以84.5億美元的銷售額位居該地區首位，這得益於其強大的診所網絡和跨境患者湧入。緊隨其後的是美國，銷售額為67.8億美元，法國為52.3億美元。 CE認證等監管框架促使產品在美國迅速普及，非侵入性手術在該地區的總銷售額中佔近189億美元。

預計北美將繼續保持其強勁地位，到2033年將佔全球市場的35.6%。該地區目前的銷售額為435億美元，其中美國憑藉其15,600家醫療水療中心和超過4,200家整形外科中心佔主導地位。加州、德州和佛羅裡達州是最大的貢獻者，光是加州就貢獻了78.9億美元。社群媒體驅動的消費者意識、FDA批准的創新技術以及不斷增加的整形美容報銷額度，為長期成長提供了支持。

美國仍是北美的醫療實力中心。該國在診所密度、創新和美容手術數量方面處於領先地位。診所每年平均在美容設備上花費48.5萬美元，預計2024年將有23項新的FDA設備核准。從業者受益於積極的數位受眾，他們通常會將社群媒體粉絲轉化為一群高價值患者。

亞太地區是成長最快的地區。美容醫療市場的年增率超過42.3億美元，這主要得益於韓國首爾8,900家診所、規模達63.4億美元的市場。中國擁有145.6億美元的市場，受益於廣泛的從業者基礎和不斷壯大的中產階級。日本憑藉在設備製造領域的領先地位，貢獻了78.9億美元的市場。新加坡已成為區域教育中心，而泰國正大力投資美容醫療旅遊，作為其更廣泛的醫療保健策略的一部分。該地區擁有 125,000 名美容醫療服務提供者，人均年支出超過 1,450 美元。

各地區

  • 北美
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 西歐
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他
  • 東歐
  • 波蘭
  • 俄羅斯
  • 其他
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲·紐西蘭
  • 韓國
  • ASEAN
  • 其他地區
  • 中東·非洲(MEA)
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 其他
  • 南美
  • 阿根廷
  • 巴西
  • 其他

主要市場參與者

美容醫療市場的主要參與者正在投資臨床教育、產品創新和全球擴張，以確保競爭優勢。主要參與者包括：

  • Cynosure
  • Johnson & Johnson
  • Galderma
  • Alma lasers
  • Allergan Inc.
  • Solta Medical
  • Lumenis
  • Syneron Candela
  • Cutera Inc.
  • El.En. S.p.A.
  • Sciton Inc.
  • Galderma
  • InMode
  • Venus Concept
  • Merz Aesthetics
  • Lutronic
  • BTL Group
  • Revance therapeutics
  • 其他的主要企業

目錄

第1章 調查架構

第2章 調查手法

第3章 摘要整理:全球美容醫療市場

第4章 全球美容醫療市場概要

  • 產業價值鏈分析
  • 產業展望
  • 大環境分析
  • 波特的五力分析
  • 市場動態和趨勢
  • COVID-19對市場成長趨勢的影響評估
  • 市場成長與展望
  • 競爭儀表板

第5章 美容醫療市場分析(各手術類型)

  • 重要的洞察
  • 市場規模與預測，2020年～2033年(10億美元)
    • 軟體

第6章 美容醫療市場分析(各功能)

  • 重要的洞察
  • 市場規模與預測，2020年～2033年(10億美元)
    • 搜尋、發現與引導
    • 行銷活動管理
    • 網紅關係管理
    • 風險與合規
    • 合約與付款管理
    • 分析與報告
    • 其他（流程自動化與最佳化）

第7章 美容醫療市場分析(各手術類型)

  • 重要的洞察
  • 市場規模與預測，2020年～2033年(10億美元)
    • 侵入性治療
    • 非侵入性治療

第8章 美容醫療市場分析(各地區)

  • 重要的洞察
  • 市場規模與預測，2020年～2033年(10億美元)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第9章 北美的美容醫療市場分析

第10章 歐洲的美容醫療市場分析

第11章 亞太地區的美容醫療市場分析

第12章 中東·非洲的美容醫療市場分析

第13章 南美的美容醫療市場分析

第14章 企業簡介

  • Cynosure
  • Johnson &johnson
  • Galderma
  • Alma lasers
  • Allergan Inc.
  • Solta Medical
  • Lumenis
  • Syneron Candela
  • Cutera Inc.
  • El.En. SpA
  • Sciton Inc.
  • Galderma
  • InMode
  • Venus Concept
  • Merz Aesthetics
  • Lutronic
  • BTL Group
  • Revance therapeutics
簡介目錄
Product Code: AA0124769

The aesthetic medicine market is transitioning from niche luxury to mainstream self-care, fueled by evolving consumer preferences, advancing technologies, and expanded access to non-invasive and minimally invasive solutions. Valued at US$ 83.12 billion in 2024, the market is projected to reach US$ 233.67 billion by 2033, growing at a robust CAGR of 12.17% during the forecast period. Procedures such as Botox, body sculpting, and skin rejuvenation have become routine for millions, likened to dental hygiene in their regularity, supported by an ecosystem of med-spas, dermatology clinics, and emerging aesthetic-focused primary care models.

The International Society of Aesthetic Plastic Surgery logged approximately 35 million treatments globally in 2023, reflecting the sector's rapid consumer uptake. Simultaneously, venture funding into aesthetic medical device companies exceeded US$ 2.9 billion in the same year, underscoring strong institutional confidence in the market's long-term growth trajectory. From nurse-led injectable services to dental clinics offering cosmetic procedures, aesthetic medicine is now embedded in broader health and wellness frameworks.

Noteworthy Market Developments

Key developments span across both the provider and device innovation landscapes. Millennial and Gen-Z consumers are fueling demand for neuromodulators, lip enhancement, and preventive anti-aging treatments, while male clientele increasingly seek hair restoration, body contouring, and jawline definition. Emerging technologies such as picosecond lasers and radio-frequency microneedling have introduced multi-benefit platforms capable of tightening, resurfacing, and pigment correction in one session.

Meanwhile, AI-driven 3D imaging solutions are transforming patient consultations by accurately forecasting treatment outcomes and optimizing dosage. Leading market participants-Allergan Aesthetics, Galderma, Cynosure, Lumenis, Therapie Clinic, and SKINovative-are building vertically integrated models, acquiring smaller players, and offering device-leasing bundles with pay-per-use and revenue-sharing options to encourage clinic adoption at scale.

Core Growth Drivers

The main growth engine for the aesthetic medicine market is the overwhelming demand for non-invasive procedures with minimal downtime. In 2024, global revenues from non-invasive treatments totaled US$ 78.5 billion. Treatments like HIFU, radiofrequency-based systems (including Thermage and Morpheus8), and laser resurfacing offer outcomes that increasingly rival traditional surgical methods without recovery periods. Clinical data show ultrasound-based devices achieve collagen contraction depths comparable to facelifts, while appointments for "lunch-hour" procedures have surged at major urban clinics.

Investment is heavily concentrated in this segment, with US$ 1.89 billion of venture capital directed toward non-invasive platforms in 2023. Clinics report superior profitability metrics for non-invasive offerings-SKINovative's average revenue per square foot reaches US$ 12,500, well ahead of US$ 8,900 for surgical setups. Furthermore, device manufacturers are innovating at a record pace: Cynosure's Elite iQ and similar multi-wavelength platforms reduce equipment redundancy and increase per-day patient throughput by over 4.5 times compared to legacy systems.

Emerging Technology Trends

One defining trend is the integration of aesthetic services into non-traditional settings, especially dental practices and med-spas. This diversification segment contributes more than US$ 23.4 billion annually. Dental groups, such as Heartland Dental and Aspen Dental, now offer injectables and facial aesthetics across hundreds of locations, leveraging existing clinical competencies. For instance, Aspen Dental invested US$ 67 million to upskill its providers, generating over US$ 780,000 in new revenue per location annually.

The med-spa model is equally dynamic, with over 8,750 operational locations in North America generating a combined US$ 15.6 billion in revenue. Therapie Clinic exemplifies this success, achieving US$ 3.2 million in average annual revenue per location with a menu of 45 services. Even primary care providers are entering the field-VillageMD allocated US$ 125 million to add aesthetic offerings across 680 clinics. Equipment companies like Lumenis are supporting these moves by offering innovative financing packages that reduce capital expenditure burdens and promote faster adoption.

Barriers to Optimization

A significant hurdle in the aesthetic medicine market is maintaining procedural consistency across large and expanding networks. Variations in injection technique and treatment application result in elevated patient dissatisfaction and liability exposure, costing the sector an estimated US$ 8.9 billion annually. One leading European network faced US$ 12 million in legal settlements tied to inconsistent treatment results.

To mitigate these challenges, leading operators are investing in proprietary training systems and AI-assisted treatment platforms. SKINovative's Clinical Excellence Platform, backed by US$ 47 million in development funding, utilizes computer vision and real-time feedback to standardize needle depth and angle, reducing practitioner variation to under 2mm. Nevertheless, system-wide implementation remains costly-requiring as much as US$ 780,000 in upfront capital per location and US$ 145,000 annually for maintenance.

Global standardization also faces regulatory hurdles. Protocols approved in one country may not comply elsewhere, leading to compliance risk and fragmented patient outcomes. In response, Allergan Aesthetics has invested US$ 167 million in training academies, while Galderma's "One Standard" initiative seeks to certify 45,000 providers globally by 2026, highlighting the industry's push toward consistent quality and safety.

Detailed Market Segmentation

Market Segment Analysis

By Procedure Type, non-invasive treatments hold the largest share, exceeding 52% of the global aesthetic medicine market in 2024. This segment includes Botox, dermal fillers, chemical peels, and laser therapies-procedures that provide effective, fast-acting results with minimal discomfort or downtime. A high projected CAGR of 12.39% indicates continued dominance as aging populations, especially in urban centers, opt for non-surgical cosmetic maintenance.

Advanced formulations and technologies have enhanced both efficacy and safety, encouraging broader adoption. Clinics and med-spas have benefited from the accessibility of these treatments, offering walk-in options that match evolving consumer preferences for convenience and discretion.

Segment Breakdown

By Procedure Type

  • Invasive Procedures
  • Breast augmentation
  • Liposuction
  • Nose reshaping
  • Eyelid Surgery
  • Tummy tuck
  • Others
  • Non-Invasive Procedures
  • Botox injections
  • Soft tissue fillers
  • Chemical peel
  • Laser hair removal
  • Microdermabrasion
  • Others

Geographic Insights

Region Segment Analysis

Europe continues to lead the global aesthetic medicine market, holding a 27.7% share and generating US$ 30.97 billion in annual revenue. Germany is the regional leader with US$ 8.45 billion, supported by a strong network of clinics and cross-border patient inflows. The United Kingdom and France follow, contributing US$ 6.78 billion and US$ 5.23 billion respectively. Regulatory frameworks such as CE marking enable swift product adoption across EU nations, while non-invasive procedures account for nearly US$ 18.9 billion of the total regional revenue.

North America is positioned to retain its status as the powerhouse, expected to secure 35.6% of the global market by 2033. The region currently generates US$ 43.5 billion in revenue, with the U.S. dominating performance through 15,600 med-spas and over 4,200 plastic surgery centers. California, Texas, and Florida are the largest contributors, with California alone accounting for US$ 7.89 billion. Social media-fueled consumer awareness, FDA-cleared innovations, and growing reimbursement for reconstructive aesthetics support long-term growth.

The United States remains the centerpiece of North American strength. The country leads in clinic density, technological innovation, and aesthetic procedure volume. Clinics spend an average of US$ 485,000 annually on aesthetic equipment, and 2024 saw 23 new FDA device clearances. Practitioners benefit from engaged digital audiences, often converting social media followings into high-value patient flows.

Asia Pacific emerges as the fastest-growing region. Annual growth in the aesthetic medicine market exceeds US$ 4.23 billion, led by South Korea's US$ 6.34 billion market across 8,900 clinics in Seoul. China, with a market value of US$ 14.56 billion, benefits from a broad base of practitioners and a rising middle class. Japan contributes US$ 7.89 billion through its leadership in device manufacturing. Singapore has become a regional education hub, while Thailand is investing heavily in aesthetic medical tourism as part of its broader healthcare strategy. The region serves 125,000 aesthetic providers, with per capita spending exceeding US$ 1,450 annually.

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Leading Market Participants

Key players in the aesthetic medicine market are investing in clinical education, product innovation, and global expansion to secure competitive advantages. Top participants include:

  • Cynosure
  • Johnson & Johnson
  • Galderma
  • Alma lasers
  • Allergan Inc.
  • Solta Medical
  • Lumenis
  • Syneron Candela
  • Cutera Inc.
  • El.En. S.p.A.
  • Sciton Inc.
  • Galderma
  • InMode
  • Venus Concept
  • Merz Aesthetics
  • Lutronic
  • BTL Group
  • Revance therapeutics
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

Chapter 2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
  • 2.4. Assumption for the Study
  • 2.5. Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Aesthetic Medicine Market

Chapter 4. Global Aesthetic Medicine Market Overview

  • 4.1. Industry Value Chain Analysis
  • 4.2. Industry Outlook
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Covid-19 Impact Assessment on Market Growth Trend
  • 4.7. Market Growth and Outlook
    • 4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020-2033
    • 4.7.2. Price Trend Analysis, by Product
  • 4.8. Competition Dashboard
    • 4.8.1. Market Concentration Rate
    • 4.8.2. Company Market Share Analysis (Value %), 2024
    • 4.8.3. Competitor Mapping

Chapter 5. Aesthetic Medicine Market Analysis, By Procedure Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 5.2.1. Software
      • 5.2.1.1. Services

Chapter 6. Aesthetic Medicine Market Analysis, by Function

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 6.2.1. Search, Discovery & Onboarding
    • 6.2.2. Campaign Management
    • 6.2.3. Influencer Relationship Management
    • 6.2.4. Risk & Compliance
    • 6.2.5. Contract & Pay Management
    • 6.2.6. Analytics & Reporting
    • 6.2.7. Others (Process Automation & Optimization)

Chapter 7. Aesthetic Medicine Market Analysis, by Procedure Type

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 7.2.1. Invasive Procedures
    • 7.2.2. Non-Invasive Procedures

Chapter 8 Aesthetic Medicine Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa

Chapter 9 North America Aesthetic Medicine Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 9.2.1 By Procedure Type
    • 9.2.2 By Function
    • 9.2.3 By Procedure Type
    • 9.2.4 By Country

Chapter 10 Europe Aesthetic Medicine Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 10.2.1 By Procedure Type
    • 10.2.2 By Function
    • 10.2.3 By Procedure Type
    • 10.2.4 By Country

Chapter 11 Asia Pacific Aesthetic Medicine Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 11.2.1 By Procedure Type
    • 11.2.2 By Function
    • 11.2.3 By Procedure Type
    • 11.2.4 By Country

Chapter 12 Middle East & Africa Aesthetic Medicine Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 12.2.1 By Procedure Type
    • 12.2.2 By Function
    • 12.2.3 By Procedure Type
    • 12.2.4 By Country

Chapter 13 South America Aesthetic Medicine Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020-2033 (US$ Bn)
    • 13.2.1 By Procedure Type
    • 13.2.2 By Function
    • 13.2.3 By Procedure Type
    • 13.2.4 By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook) *

  • 14.1. Cynosure
  • 14.2. Johnson & johnson
  • 14.3. Galderma
  • 14.4. Alma lasers
  • 14.5. Allergan Inc.
  • 14.6. Solta Medical
  • 14.7. Lumenis
  • 14.8. Syneron Candela
  • 14.9. Cutera Inc.
  • 14.10. El.En. S.p.A.
  • 14.11. Sciton Inc.
  • 14.12. Galderma
  • 14.13. InMode
  • 14.14. Venus Concept
  • 14.15. Merz Aesthetics
  • 14.16. Lutronic
  • 14.16. BTL Group
  • 14.18. Revance therapeutics